Azolopyrimidine-Based Thioethers: Synthesis via Cross-Dehydrogenative C-S Coupling and In Silico Evaluation of Anti-SARS-CoV-2 Activity.

IF 3 4区 化学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Alexey A Akulov, Anastasia I Silaeva, Mikhail V Varaksin, Ilya I Butorin, Daniil N Lyapustin, Roman A Drokin, Svetlana K Kotovskaya, Anna V Zaykovskaya, Oleg V Pyankov, Vladimir L Rusinov, Valery N Charushin, Oleg N Chupakhin
{"title":"Azolopyrimidine-Based Thioethers: Synthesis via Cross-Dehydrogenative C-S Coupling and In Silico Evaluation of Anti-SARS-CoV-2 Activity.","authors":"Alexey A Akulov, Anastasia I Silaeva, Mikhail V Varaksin, Ilya I Butorin, Daniil N Lyapustin, Roman A Drokin, Svetlana K Kotovskaya, Anna V Zaykovskaya, Oleg V Pyankov, Vladimir L Rusinov, Valery N Charushin, Oleg N Chupakhin","doi":"10.1002/cplu.202400594","DOIUrl":null,"url":null,"abstract":"<p><p>Azoloazine derivatives are known as promising small molecules that are potentially able to counteract a broad spectrum of RNA viruses including SARS-CoV-2. However, a pool of synthetic pathways to provide convenient structural modification of such compounds without de novo construction of the heterocyclic scaffold is rather limited so far. This work proposes an approach to the direct C(sp2)-H functionalization of azolopyrimidine substrates with aromatic thiol residues, mediated by the iodine/persulfate reagent system. The reported herein sulfenylation protocol has afforded a series of previously undescribed azolopyrimidine-based thioethers obtained in yields of up to 87%. Applicability of the approach to the selenium-centered synthons has been demonstrated as well. Besides, the in silico study with regard to the achieved cross-coupling products has suggested the possible affinity to the SARS-CoV-2 main protease (Mpro), as follows from the conducted pharmacophore search and the molecular docking experiments. As a result, the developed synthetic transformation is expected to be of utility in the design of novel antiviral agents based on small azaheterocyclic molecules.</p>","PeriodicalId":148,"journal":{"name":"ChemPlusChem","volume":" ","pages":"e202400594"},"PeriodicalIF":3.0000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemPlusChem","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1002/cplu.202400594","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Azoloazine derivatives are known as promising small molecules that are potentially able to counteract a broad spectrum of RNA viruses including SARS-CoV-2. However, a pool of synthetic pathways to provide convenient structural modification of such compounds without de novo construction of the heterocyclic scaffold is rather limited so far. This work proposes an approach to the direct C(sp2)-H functionalization of azolopyrimidine substrates with aromatic thiol residues, mediated by the iodine/persulfate reagent system. The reported herein sulfenylation protocol has afforded a series of previously undescribed azolopyrimidine-based thioethers obtained in yields of up to 87%. Applicability of the approach to the selenium-centered synthons has been demonstrated as well. Besides, the in silico study with regard to the achieved cross-coupling products has suggested the possible affinity to the SARS-CoV-2 main protease (Mpro), as follows from the conducted pharmacophore search and the molecular docking experiments. As a result, the developed synthetic transformation is expected to be of utility in the design of novel antiviral agents based on small azaheterocyclic molecules.

偶氮嘧啶基硫醚:通过交叉脱氢 C-S 偶联合成和抗 SARS-CoV-2 活性的硅学评估。
众所周知,偶氮嗪衍生物是一种前景广阔的小分子,有可能对抗包括 SARS-CoV-2 在内的多种 RNA 病毒。然而,迄今为止,无需重新构建杂环支架就能方便地对此类化合物进行结构修饰的合成途径非常有限。本研究提出了一种在碘/过硫酸盐试剂系统介导下,用芳香硫醇残基对偶氮嘧啶底物进行直接 C(sp2)-H 功能化的方法。本文所报道的亚磺酰化协议提供了一系列以前未曾描述过的偶氮嘧啶硫醚,收率高达 87%。该方法还适用于以硒为中心的合成物。此外,通过药理搜索和分子对接实验,对所获得的交叉耦合产物进行的硅学研究表明,它们可能与 SARS-CoV-2 主要蛋白酶(Mpro)有亲和力。因此,所开发的合成转化技术有望用于设计基于杂环小分子的新型抗病毒药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ChemPlusChem
ChemPlusChem CHEMISTRY, MULTIDISCIPLINARY-
CiteScore
5.90
自引率
0.00%
发文量
200
审稿时长
1 months
期刊介绍: ChemPlusChem is a peer-reviewed, general chemistry journal that brings readers the very best in multidisciplinary research centering on chemistry. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. Fully comprehensive in its scope, ChemPlusChem publishes articles covering new results from at least two different aspects (subfields) of chemistry or one of chemistry and one of another scientific discipline (one chemistry topic plus another one, hence the title ChemPlusChem). All suitable submissions undergo balanced peer review by experts in the field to ensure the highest quality, originality, relevance, significance, and validity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信